BioClec
PrivateLast Round
Seed
Mar 18, 2025
Company Overview
BioClec is a biotechnology company developing therapies for Alzheimer's disease by targeting microglia, the brain's immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioClec Comparables
Compare BioClec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monument Biosciences | 86% | |
| Vigil Neuro | 77% | |
| Modulo Bio | 77% |
BioClec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2025 |
BioClec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Led by Sofinnova Partners.
BioClec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioClec's valuation, stock price, and market status.
Is BioClec a public or private company?
BioClec is a private company.
What is the current stock price of BioClec?
BioClec is a private company with no public stock price. No recent secondary market data is available.
How much is BioClec worth (valuation)?
Valuation information for BioClec is not publicly available.
Can I buy BioClec stock?
BioClec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioClec's last funding round?
BioClec's most recent funding round was Seed on March 18, 2025.
Who are the main investors in BioClec?
Key investors in BioClec include Sofinnova Partners.
Will BioClec IPO soon?
No public IPO plans have been announced for BioClec.
How can I track BioClec secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioClec's secondary market activity and sign up for updates.